Mannose-binding lectin, a multifunctional molecule of the innate immune system: Biology, genetics and disease association

Genetic Predisposition to Disease

Volumn , Issue , 2008, Pages 119-174

  Messias Reason, Iara De ^a   Boldt, Angelica B W ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953981427     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (327)

1. Holmskov, U; Thiel, S; Jensenius, JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol, 2003, 21, 547-578.
2. Bohlson, SS; Fraser, DA; Tenner, AJ. Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol, 2007, 44, 33-43.
3. Endo, Y; Liu, Y; Fujita, T. Structure and function of ficolins. Adv Exp Med Biol, 2006, 586, 265-279.
4. Endo, Y; Matsushita, M; Fujita, T. Role of ficolin in innate immunity and its molecular basis. Immunobiology, 2007, 212, 371-379.
5. Fujita, T; Matsushita, M; Endo, Y. The lectin-complement pathway--its role in innate immunity and evolution. Immunol Rev, 2004, 198, 185-202.
6. Sastry, R; Wang, JS; Brown, DC; Ezekowitz, RA; Tauber, AI; Sastry, KN. Characterization of murine mannose-binding protein genes Mbl1 and Mbl2 reveals features common to other collectin genes. Mamm Genome, 1995, 6, 103-110.
7. Mogues, T; Ota, T; Tauber, AI; Sastry, KN. Characterization of two mannose-binding protein cDNAs from rhesus monkey (Macaca mulatta): structure and evolutionary implications. Glycobiology, 1996, 6, 543-550.
8. Seyfarth, J; Garred, P; Madsen, HO. The 'involution' of mannose-binding lectin. Hum Mol Genet, 2005, 14, 2859-2869.
9. Dumestre-Perard, C; Ponard, D; Colomb, MG. Analysis of low molecular weight intracellular associations of a human mannan binding lectin (MBL). Mol Immunol, 2004, 40, 795-801.
10. Kurata, H; Sannoh, T; Kozutsumi, Y; Yokota, Y; Kawasaki, T. Structure and function of mannan-binding proteins isolated from human liver and serum. J Biochem, 1994, 115, 1148-1154.
11. Sastry, K; Herman, GA; Day, L; Deignan, E; Bruns, G; Morton, CC; Ezekowitz, RA. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med, 1989, 170, 1175-1189.
12. Guo, N; Mogues, T; Weremowicz, S; Morton, CC; Sastry, KN. The human ortholog of rhesus mannose-binding protein-A gene is an expressed pseudogene that localizes to chromosome 10. Mamm Genome, 1998, 9, 246-249.
13. Kolble, K; Reid, KB. The genomics of soluble proteins with collagenous domains: C1q, MBL, SP-A, SP-D, conglutinin, and CL-43. Behring Inst Mitt, 1993, 81-86.
14. Ezekowitz, RA; Day, LE; Herman, GA. A human mannose-binding protein is an acutephase reactant that shares sequence homology with other vertebrate lectins. J Exp Med, 1988, 167, 1034-1046.
15. Verga Falzacappa, MV; Segat, L; Puppini, B; Amoroso, A; Crovella, S. Evolution of the mannose-binding lectin gene in primates. Genes Immun, 2004, 5, 653-661.
16. Schweinle, JE; Nishiyasu, M; Ding, TQ; Sastry, K; Gillies, SD; Ezekowitz, RA. Truncated forms of mannose-binding protein multimerize and bind to mannose-rich Salmonella montevideo but fail to activate complement in vitro. J Biol Chem, 1993, 268, 364-370.
17. Taylor, ME; Brickell, PM; Craig, RK; Summerfield, JA. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J, 1989, 262, 763-771.
18. Weis, WI; Taylor, ME; Drickamer, K. The C-type lectin superfamily in the immune system. Immunol Rev, 1998, 163, 19-34.
19. Weis, WI; Drickamer, K; Hendrickson, WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature, 1992, 360, 127-134.
20. Drickamer, K. Engineering galactose-binding activity into a C-type mannose-binding protein. Nature, 1992, 360, 183-186.
21. Larsen, F; Madsen, HO; Sim, RB; Koch, C; Garred, P. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem, 2004, 279, 21302-21311.
22. Wallis, R; Drickamer, K. Asymmetry adjacent to the collagen-like domain in rat liver mannose-binding protein. Biochem J, 1997, 325 ( Pt 2), 391-400.
23. Wallis, R; Drickamer, K. Molecular determinants of oligomer formation and complement fixation in mannose-binding proteins. J Biol Chem, 1999, 274, 3580-3589.
24. Lipscombe, RJ; Sumiya, M; Summerfield, JA; Turner, MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology, 1995, 85, 660-667.
25. Yokota, Y; Arai, T; Kawasaki, T. Oligomeric structures required for complement activation of serum mannan-binding proteins. J Biochem, 1995, 117, 414-419.
26. Lee, SG; Yum, JS; Moon, HM; Kim, HJ; Yang, YJ; Kim, HL; Yoon, Y; Lee, S; Song, K. Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. Mol Immunol, 2005, 42, 969-977.
27. Roos, A; Garred, P; Wildenberg, ME; Lynch, NJ; Munoz, JR; Zuiverloon, TC; Bouwman, LH; Schlagwein, N; Fallaux van den Houten FC; Faber-Krol, MC; Madsen, HO; Schwaeble, WJ; Matsushita, M; Fujita, T; Daha, MR. Antibody-mediated activation of the classical pathway of complement may compensate for mannosebinding lectin deficiency. Eur J Immunol, 2004, 34, 2589-2598.
28. Lu, JH; Thiel, S; Wiedemann, H; Timpl, R; Reid, KB. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol, 1990, 144, 2287-2294.
29. Kawasaki, N; Kawasaki, T; Yamashina, I. Isolation and characterization of a mannanbinding protein from human serum. J Biochem, 1983, 94, 937-947.
30. Lee, RT; Ichikawa, Y; Fay, M; Drickamer, K; Shao, MC; Lee, YC. Ligand-binding characteristics of rat serum-type mannose-binding protein (MBP-A). Homology of binding site architecture with mammalian and chicken hepatic lectins. J Biol Chem, 1991, 266, 4810-4815.
31. Naito, H; Ikeda, A; Hasegawa, K; Oka, S; Uemura, K; Kawasaki, N; Kawasaki, T. Characterization of human serum mannan-binding protein promoter. J Biochem (Tokyo), 1999, 126, 1004-1012.
32. Thiel, S; Holmskov, U; Hviid, L; Laursen, SB; Jensenius, JC. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol, 1992, 90, 31-35.
33. Steffensen, R; Thiel, S; Varming, K; Jersild, C; Jensenius, JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods, 2000, 241, 33-42.
34. Arai, T; Tabona, P; Summerfield, JA. Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock. Q J Med, 1993, 86, 575-582.
35. Sorensen, CM; Hansen, TK; Steffensen, R; Jensenius, JC; Thiel, S. Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clin Exp Immunol, 2006, 145, 173-182.
36. Gravholt, CH; Leth-Larsen, R; Lauridsen, AL; Thiel, S; Hansen, TK; Holmskov, U; Naeraa, RW; Christiansen, JS. The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. Eur J Endocrinol, 2004, 150, 355-362.
37. Hansen, TK; Thiel, S; Dall, R; Rosenfalck, AM; Trainer, P; Flyvbjerg, A; Jorgensen, JO; Christiansen, JS. GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab, 2001, 86, 5383-5388.
38. Malhotra, R; Wormald, MR; Rudd, PM; Fischer, PB; Dwek, RA; Sim, RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med, 1995, 1, 237-243.
39. Malhotra, R; Willis, AC; Lopez, BA; Thiel, S; Sim, RB. Mannan-binding protein levels in human amniotic fluid during gestation and its interaction with collectin receptor from amnion cells. Immunology, 1994, 82, 439-444.
40. Gomi, K; Tokue, Y; Kobayashi, T; Takahashi, H; Watanabe, A; Fujita, T; Nukiwa, T. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest, 2004, 126, 95-99.
41. Babula, O; Lazdane, G; Kroica, J; Ledger, WJ; Witkin, SS. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis, 2003, 37, 733-737.
42. Pellis, V; De Seta, F; Crovella, S; Bossi, F; Bulla, R; Guaschino, S; Radillo, O; Garred, P; Tedesco, F. Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin Exp Immunol, 2005, 139, 120-126.
43. Tregoat, V; Montagne, P; Bene, MC; Faure, G. Changes in the mannan binding lectin (MBL) concentration in human milk during lactation. J Clin Lab Anal, 2002, 16, 304-307.
44. Seyfarth, J; Garred, P; Madsen, HO. Extra-hepatic transcription of the human mannosebinding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol Immunol, 2006, 43, 962-971.
45. van de Geijn, FE; Roos, A; de Man, YA; Laman, JD; de Groot, CJ; Daha, MR; Hazes, JM; Dolhain, RJ. Mannose-binding lectin levels during pregnancy: a longitudinal study. Hum Reprod, 2007, 22, 362-371.
46. Aittoniemi, J; Miettinen, A; Laippala, P; Isolauri, E; Viikari, J; Ruuska, T; Soppi, E. Age-dependent variation in the serum concentration of mannan-binding protein. Acta Paediatr, 1996, 85, 906-909.
47. Lau, YL; Chan, SY; Turner, MW; Fong, J; Karlberg, J. Mannose-binding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol, 1995, 102, 649-654.
48. Terai, I; Kobayashi, K. Perinatal changes in serum mannose-binding protein (MBP) levels. Immunol Lett, 1993, 38, 185-187.
49. Thiel, S; Bjerke, T; Hansen, D; Poulsen, LK; Schiotz, PO; Jensenius, JC. Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr Allergy Immunol, 1995, 6, 20-23.
50. Terai, I; Kobayashi, K; Fujita, T; Hagiwara, K. Human serum mannose binding protein (MBP): development of an enzyme-linked immunosorbent assay (ELISA) and determination of levels in serum from 1085 normal Japanese and in some body fluids. Biochem Med Metab Biol, 1993, 50, 111-119.
51. Ip, WK; To, YF; Cheng, SK; Lau, YL. Serum mannose-binding lectin levels and mbl2 gene polymorphisms in different age and gender groups of southern Chinese adults. Scand J Immunol, 2004, 59, 310-314.
52. Super, M; Thiel, S; Lu, J; Levinsky, RJ; Turner, MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet, 1989, 2, 1236-1239.
53. Colley, KJ; Baenziger, JU. Biosynthesis and secretion of the rat core-specific lectin. Relationship of post-translational modification and assembly to attainment of carbohydrate binding activity. J Biol Chem, 1987, 262, 3415-3421.
54. Drickamer, K; Dordal, MS; Reynolds, L. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J Biol Chem, 1986, 261, 6878-6887.
55. Colley, KJ; Baenziger, JU. Identification of the post-translational modifications of the core-specific lectin. The core-specific lectin contains hydroxyproline, hydroxylysine, and glucosylgalactosylhydroxylysine residues. J Biol Chem, 1987, 262, 10290-10295.
56. Bornstein, P. The structure and assembly of procollagen-a review. J Supramol Struct, 1974, 2, 108-120.
57. Heise, CT; Nicholls, JR; Leamy, CE; Wallis, R. Impaired secretion of rat mannosebinding protein resulting from mutations in the collagen-like domain. J Immunol, 2000, 165, 1403-1409.
58. Jensen, PH; Weilguny, D; Matthiesen, F; McGuire, KA; Shi, L; Hojrup, P. Characterization of the oligomer structure of recombinant human mannan-binding lectin. J Biol Chem, 2005, 280, 11043-11051.
59. Kilpatrick, DC. Phospholipid-binding activity of human mannan-binding lectin. Immunol Lett, 1998, 61, 191-195.
60. Palaniyar, N; Nadesalingam, J; Reid, KB. Innate immune collectins bind nucleic acids and enhance DNA clearance in vitro. Ann N Y Acad Sci, 2003, 1010, 467-470.
61. Estabrook, MM; Jack, DL; Klein, NJ; Jarvis, GA. Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis. J Immunol, 2004, 172, 3784-3792.
62. Neth, O; Jack, DL; Dodds, AW; Holzel, H; Klein, NJ; Turner, MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun, 2000, 68, 688-693.
63. Kawakami, M; Ihara, I; Suzuki, A; Harada, Y. Properties of a new complementdependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice. J Immunol, 1982, 129, 2198-2201.
64. Devyatyarova-Johnson, M; Rees, IH; Robertson, BD; Turner, MW; Klein, NJ; Jack, DL. The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms. Infect Immun, 2000, 68, 3894-3899.
65. Jack, DL; Dodds, AW; Anwar, N; Ison, CA; Law, A; Frosch, M; Turner, MW; Klein, NJ. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol, 1998, 160, 1346-1353.
66. Dommett, RM; Klein, N; Turner, MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens, 2006, 68, 193-209.
67. Porter, RR; Reid, KB. The biochemistry of complement. Nature, 1978, 275, 699-704.
68. Carroll, MC. The complement system in regulation of adaptive immunity. Nat Immunol, 2004, 5, 981-986.
69. Ikeda, K; Sannoh, T; Kawasaki, N; Kawasaki, T; Yamashina, I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem, 1987, 262, 7451-7454.
70. Schwaeble, W; Dahl, MR; Thiel, S; Stover, C; Jensenius, JC. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes. Immunobiology, 2002, 205, 455-466.
71. Dahl, MR; Thiel, S; Matsushita, M; Fujita, T; Willis, AC; Christensen, T; Vorup-Jensen, T; Jensenius, JC. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity, 2001, 15, 127-135.
72. Nonaka, M; Miyazawa, S. Evolution of the initiating enzymes of the complement system. Genome Biol, 2002, 3, REVIEWS1001.
73. Stover, CM; Thiel, S; Thelen, M; Lynch, NJ; Vorup-Jensen, T; Jensenius, JC; Schwaeble, WJ. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol, 1999, 162, 3481-3490.
74. Takahashi, M; Endo, Y; Fujita, T; Matsushita, M. A truncated form of mannosebinding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int Immunol, 1999, 11, 859-863.
75. Chen, CB; Wallis, R. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units for complement activation. J Biol Chem, 2001, 276, 25894-25902.
76. Thielens, NM; Cseh, S; Thiel, S; Vorup-Jensen, T; Rossi, V; Jensenius, JC; Arlaud, GJ. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and-2, MBL-associated protein 19, and MBL. J Immunol, 2001, 166, 5068-5077.
77. Vorup-Jensen, T; Petersen, SV; Hansen, AG; Poulsen, K; Schwaeble, W; Sim, RB; Reid, KB; Davis, SJ; Thiel, S; Jensenius, JC. Distinct pathways of mannan-binding lectin (MBL)-and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol, 2000, 165, 2093-2100.
78. Matsushita, M; Thiel, S; Jensenius, JC; Terai, I; Fujita, T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol, 2000, 165, 2637-2642.
79. Rossi, V; Cseh, S; Bally, I; Thielens, NM; Jensenius, JC; Arlaud, GJ. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and-2. J Biol Chem, 2001, 276, 40880-40887.
80. Degn, SE; Thiel, S; Jensenius, JC. New perspectives on mannan-binding lectinmediated complement activation. Immunobiology, 2007, 212, 301-311.
81. Gal, P; Harmat, V; Kocsis, A; Bian, T; Barna, L; Ambrus, G; Vegh, B; Balczer, J; Sim, RB; Naray-Szabo, G; Zavodszky, P. A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations. J Biol Chem, 2005, 280, 33435-33444.
82. Wallis, R; Dodds, AW; Mitchell, DA; Sim, RB; Reid, KB; Schwaeble, WJ. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway. J Biol Chem, 2007, 282, 7844-7851.
83. Moller-Kristensen, M; Thiel, S; Sjoholm, A; Matsushita, M; Jensenius, JC. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int Immunol, 2007, 19, 141-149.
84. Matsushita, M; Fujita, T. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation. Immunobiology, 1995, 194, 443-448.
85. Brouwer, N; Dolman, KM; van Zwieten, R; Nieuwenhuys, E; Hart, M; Aarden, LA; Roos, D; Kuijpers, TW. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol, 2006, 43, 2051-2060.
86. Harboe, M; Garred, P; Borgen, MS; Stahl, GL; Roos, A; Mollnes, TE. Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Clin Exp Immunol, 2006, 144, 512-520.
87. Schweinle, JE; Ezekowitz, RA; Tenner, AJ; Kuhlman, M; Joiner, KA. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J Clin Invest, 1989, 84, 1821-1829.
88. Selander, B; Martensson, U; Weintraub, A; Holmstrom, E; Matsushita, M; Thiel, S; Jensenius, JC; Truedsson, L; Sjoholm, AG. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest, 2006, 116, 1425-1434.
89. Groeneveld, TW; Ramwadhdoebe, TH; Trouw, LA; van den Ham, DL; van, dB, V; Drijfhout, JW; Hiemstra, PS; Daha, MR; Roos, A. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation. Mol Immunol, 2007, 44, 3608-3614.
90. Nielsen, EW; Waage, C; Fure, H; Brekke, OL; Sfyroera, G; Lambris, JD; Mollnes, TE. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Mol Immunol, 2007, 44, 1819-1826.
91. Anders, EM; Hartley, CA; Jackson, DC. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A, 1990, 87, 4485-4489.
92. Miller, ME; Seals, J; Haye, R; Levitsky, LC. A familial plasma-associated defect of phagocytosis. Lancet, 1968, 2, 60-63.
93. Soothill, JF; Harvey, BA. Defective opsonization. A common immunity deficiency. Arch Dis Child, 1976, 51, 91-99.
94. Candy, DC; Larcher, VF; Tripp, JH; Harries, JT; Harvey, BA; Soothill, JF. Yeast opsonisation in children with chronic diarrhoeal states. Arch Dis Child, 1980, 55, 189-193.
95. Turner, MW; Mowbray, JF; Roberton, DR. A study of C3b deposition on yeast surfaces by sera of known opsonic potential. Clin Exp Immunol, 1981, 46, 412-419.
96. Kuhlman, M; Joiner, K; Ezekowitz, RA. The human mannose-binding protein functions as an opsonin. J Exp Med, 1989, 169, 1733-1745.
97. Arora, M; Munoz, E; Tenner, AJ. Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis. J Biol Chem, 2001, 276, 43087-43094.
98. Tenner, AJ; Robinson, SL; Ezekowitz, RA. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity, 1995, 3, 485-493.
99. Nepomuceno, RR; Ruiz, S; Park, M; Tenner, AJ. C1qRP is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J Immunol, 1999, 162, 3583-3589.
100. Stuart, GR; Lynch, NJ; Day, AJ; Schwaeble, WJ; Sim, RB. The C1q and collectin binding site within C1q receptor (cell surface calreticulin). Immunopharmacology, 1997, 38, 73-80.
101. Ghiran, I; Barbashov, SF; Klickstein, LB; Tas, SW; Jensenius, JC; Nicholson-Weller, A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med, 2000, 192, 1797-1808.
102. Edelson, BT; Stricker, TP; Li, Z; Dickeson, SK; Shepherd, VL; Santoro, SA; Zutter, MM. Novel collectin/C1q receptor mediates mast cell activation and innate immunity. Blood, 2006, 107, 143-150.
103. Fraser, DA; Bohlson, SS; Jasinskiene, N; Rawal, N; Palmarini, G; Ruiz, S; Rochford, R; Tenner, AJ. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol, 2006, 80, 107-116.
104. Kang, HJ; Lee, SM; Lee, HH; Kim, JY; Lee, BC; Yum, JS; Moon, HM; Lee, BL. Mannose-binding lectin without the aid of its associated serine proteases alters lipopolysaccharide-mediated cytokine/chemokine secretion from human endothelial cells. Immunology, 2007, 122, 335-342.
105. Jack, DL; Read, RC; Tenner, AJ; Frosch, M; Turner, MW; Klein, NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis, 2001, 184, 1152-1162.
106. Boldt, AB; Luty, A; Grobusch, MP; Dietz, K; Dzeing, A; Kombila, M; Kremsner, PG; Kun, JF. Association of a new mannose binding lectin variant with severe malaria in Gabonese children. 2006
107. Uemura, K; Yamamoto, H; Nakagawa, T; Nakamura, K; Kawasaki, N; Oka, S; Ma, BY; Kawasaki, T. Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP). Glycoconj J, 2004, 21, 79-84.
108. Ogden, CA; deCathelineau, A; Hoffmann, PR; Bratton, D; Ghebrehiwet, B; Fadok, VA; Henson, PM. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med, 2001, 194, 781-795.
109. Nauta, AJ; Raaschou-Jensen, N; Roos, A; Daha, MR; Madsen, HO; Borrias-Essers, MC; Ryder, LP; Koch, C; Garred, P. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol, 2003, 33, 2853-2863.
110. Nauta, AJ; Castellano, G; Xu, W; Woltman, AM; Borrias, MC; Daha, MR; van Kooten, C; Roos, A. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol, 2004, 173, 3044-3050.
111. Stuart, LM; Takahashi, K; Shi, L; Savill, J; Ezekowitz, RA. Mannose-binding lectindeficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol, 2005, 174, 3220-3226.
112. Hart, ML; Ceonzo, KA; Shaffer, LA; Takahashi, K; Rother, RP; Reenstra, WR; Buras, JA; Stahl, GL. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol, 2005, 174, 6373-6380.
113. Walsh, MC; Bourcier, T; Takahashi, K; Shi, L; Busche, MN; Rother, RP; Solomon, SD; Ezekowitz, RA; Stahl, GL. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol, 2005, 175, 541-546.
114. Hakomori, S. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol, 2001, 491, 369-402.
115. Ma, Y; Uemura, K; Oka, S; Kozutsumi, Y; Kawasaki, N; Kawasaki, T. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A, 1999, 96, 371-375.
116. Nakagawa, T; Kawasaki, N; Ma, Y; Uemura, K; Kawasaki, T. Antitumor activity of mannan-binding protein. Methods Enzymol, 2003, 363, 26-33.
117. Zhu, D; McCarthy, H; Ottensmeier, CH; Johnson, P; Hamblin, TJ; Stevenson, FK. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood, 2002, 99, 2562-2568.
118. Zhu, D; Ottensmeier, CH; Du, MQ; McCarthy, H; Stevenson, FK. Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br J Haematol, 2003, 120, 217-222.
119. Radcliffe, CM; Arnold, JN; Suter, DM; Wormald, MR; Harvey, DJ; Royle, L; Mimura, Y; Kimura, Y; Sim, RB; Inoges, S; Rodriguez-Calvillo, M; Zabalegui, N; de Cerio, AL; Potter, KN; Mockridge, CI; Dwek, RA; Bendandi, M; Rudd, PM; Stevenson, FK. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J Biol Chem, 2007, 282, 7405-7415.
120. Arnold, JN; Wallis, R; Willis, AC; Harvey, DJ; Royle, L; Dwek, RA; Rudd, PM; Sim, RB. Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? J Biol Chem, 2006, 281, 6955-6963.
121. Arnold, JN; Dwek, RA; Rudd, PM; Sim, RB. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett, 2006, 106, 103-110.
122. Downing, I; Koch, C; Kilpatrick, DC. Immature dendritic cells possess a sugarsensitive receptor for human mannan-binding lectin. Immunology, 2003, 109, 360-364.
123. Downing, I; MacDonald, SL; Turner, ML; Kilpatrick, DC. Detection of an autologous ligand for mannan-binding lectin on human B lymphocytes. Scand J Immunol, 2005, 62, 507-514.
124. Hajela, K; Kojima, M; Ambrus, G; Wong, KH; Moffatt, BE; Ferluga, J; Hajela, S; Gal, P; Sim, RB. The biological functions of MBL-associated serine proteases (MASPs). Immunobiology, 2002, 205, 467-475.
125. Krarup, A; Wallis, R; Presanis, JS; Gal, P; Sim, RB. Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS ONE, 2007, 2, e623.
126. Bernig, T; Taylor, JG; Foster, CB; Staats, B; Yeager, M; Chanock, SJ. Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun, 2004, 5, 461-476.
127. Verdu, P; Barreiro, LB; Patin, E; Gessain, A; Cassar, O; Kidd, JR; Kidd, KK; Behar, DM; Froment, A; Heyer, E; Sica, L; Casanova, JL; Abel, L; Quintana-Murci, L. Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet, 2006, 15, 2650-2658.
128. Sachidanandam, R; Weissman, D; Schmidt, SC; Kakol, JM; Stein, LD; Marth, G; Sherry, S; Mullikin, JC; Mortimore, BJ; Willey, DL; Hunt, SE; Cole, CG; Coggill, PC; Rice, CM; Ning, Z; Rogers, J; Bentley, DR; Kwok, PY; Mardis, ER; Yeh, RT; Schultz, B; Cook, L; Davenport, R; Dante, M; Fulton, L; Hillier, L; Waterston, RH; McPherson, JD; Gilman, B; Schaffner, S; Van Etten, WJ; Reich, D; Higgins, J; Daly, MJ; Blumenstiel, B; Baldwin, J; Stange-Thomann, N; Zody, MC; Linton, L; Lander, ES; Altshuler, D. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 2001, 409, 928-933.
129. Boldt, AB; Culpi, L; Tsuneto, LT; de Souza, IR; Kun, JF; Petzl-Erler, ML. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum Immunol, 2006, 67, 722-734.
130. Gabolde, M; Muralitharan, S; Besmond, C. Genotyping of the three major allelic variants of the human mannose-binding lectin gene by denaturing gradient gel electrophoresis. Hum Mutat, 1999, 14, 80-83.
131. Juliger, S; Kremsner, PG; Alpers, MP; Reeder, JC; Kun, JF. Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea. Mutat Res, 2002, 505, 87-91.
132. Madsen, HO; Satz, ML; Hogh, B; Svejgaard, A; Garred, P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol, 1998, 161, 3169-3175.
133. Mombo, LE; Lu, CY; Ossari, S; Bedjabaga, I; Sica, L; Krishnamoorthy, R; Lapoumeroulie, C. Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections. Genes Immun, 2003, 4, 362-367.
134. Neonato, MG; Lu, CY; Guilloud-Bataille, M; Lapoumeroulie, C; Nabeel-Jassim, H; Dabit, D; Girot, R; Krishnamoorthy, R; Feingold, J; Besmond, C; Elion, J. Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur J Hum Genet, 1999, 7, 679-686.
135. Garred, P; Madsen, HO; Kurtzhals, JA; Lamm, LU; Thiel, S; Hey, AS; Svejgaard, A. Diallelic polymorphism may explain variations of the blood concentration of mannanbinding protein in Eskimos, but not in black Africans. Eur J Immunogenet, 1992, 19, 403-412.
136. Madsen, HO; Garred, P; Thiel, S; Kurtzhals, JA; Lamm, LU; Ryder, LP; Svejgaard, A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol, 1995, 155, 3013-3020.
137. Garred, P; Larsen, F; Madsen, HO; Koch, C. Mannose-binding lectin deficiency--revisited. Mol Immunol, 2003, 40, 73-84.
138. Sumiya, M; Super, M; Tabona, P; Levinsky, RJ; Arai, T; Turner, MW; Summerfield, JA. Molecular basis of opsonic defect in immunodeficient children. Lancet, 1991, 337, 1569-1570.
139. Wallis, R; Cheng, JY. Molecular defects in variant forms of mannose-binding protein associated with immunodeficiency. J Immunol, 1999, 163, 4953-4959.
140. Crosdale, DJ; Ollier, WE; Thomson, W; Dyer, PA; Jensenious, J; Johnson, RW; Poulton, KV. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur J Immunogenet, 2000, 27, 111-117.
141. Lipscombe, RJ; Lau, YL; Levinsky, RJ; Sumiya, M; Summerfield, JA; Turner, MW. Identical point mutation leading to low levels of mannose binding protein and poor C3b mediated opsonisation in Chinese and Caucasian populations. Immunol Lett, 1992, 32, 253-257.
142. Minchinton, RM; Dean, MM; Clark, TR; Heatley, S; Mullighan, CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol, 2002, 56, 630-641.
143. Butler, GS; Sim, D; Tam, E; Devine, D; Overall, CM. Mannose-binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis: potential role in human MBL deficiency. J Biol Chem, 2002, 277, 17511-17519.
144. Super, M; Gillies, SD; Foley, S; Sastry, K; Schweinle, JE; Silverman, VJ; Ezekowitz, RA. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet, 1992, 2, 50-55.
145. Dean, MM; Heatley, S; Minchinton, RM. Heteroligomeric forms of codon 54 mannose binding lectin (MBL) in circulation demonstrate reduced in vitro function. Mol Immunol, 2006, 43, 950-961.
146. Turner, MW; Dinan, L; Heatley, S; Jack, DL; Boettcher, B; Lester, S; McCluskey, J; Roberton, D. Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet, 2000, 9, 1481-1486.
147. Boldt, AB; Petzl-Erler, ML. A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat, 2002, 19, 296-306.
148. Cedzynski, M; Szemraj, J; Swierzko, AS; Bak-Romaniszyn, L; Banasik, M; Zeman, K; Kilpatrick, DC. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol, 2004, 136, 304-311.
149. Skalnikova, H; Freiberger, T; Chumchalova, J; Grombirikova, H; Sediva, A. Costeffective genotyping of human MBL2 gene mutations using multiplex PCR. J Immunol Methods, 2004, 295, 139-147.
150. Bernig, T; Breunis, W; Brouwer, N; Hutchinson, A; Welch, R; Roos, D; Kuijpers, T; Chanock, S. An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3' haplotypes could modify circulating levels of mannosebinding lectin. Hum Genet, 2005, 118, 404-415.
151. Wiertsema, SP; Herpers, BL; Veenhoven, RH; Salimans, MM; Ruven, HJ; Sanders, EA; Rijkers, GT. Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J Allergy Clin Immunol, 2006, 117, 1344-1350.
152. Cavalli-Sforza, LL; Feldman, MW. The application of molecular genetic approaches to the study of human evolution. Nat Genet, 2003, 33 Suppl, 266-275.
153. Lipscombe, RJ; Sumiya, M; Hill, AV; Lau, YL; Levinsky, RJ; Summerfield, JA; Turner, MW. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet, 1992, 1, 709-715.
154. Lipscombe, RJ; Beatty, DW; Ganczakowski, M; Goddard, EA; Jenkins, T; Lau, YL; Spurdle, AB; Sumiya, M; Summerfield, JA; Turner, MW. Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet, 1996, 4, 13-19.
155. Song, lH; Binh, VQ; Duy, DN; Juliger, S; Bock, TC; Luty, AJ; Kremsner, PG; Kun, JF. Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients. Mutat Res, 2003, 522, 119-125.
156. Gupta, B; Agrawal, C; Raghav, SK; Das, SK; Das, RH; Chaturvedi, VP; Das, HR. Association of mannose-binding lectin gene (MBL2) polymorphisms with rheumatoid arthritis in an Indian cohort of case-control samples. J Hum Genet, 2005, 50, 583-591.
157. Redd, AJ; Stoneking, M. Peopling of Sahul: mtDNA variation in aboriginal Australian and Papua New Guinean populations. Am J Hum Genet, 1999, 65, 808-828.
158. Dahl, M; Tybjaerg-Hansen, A; Schnohr, P; Nordestgaard, BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med, 2004, 199, 1391-1399.
159. Tacx, AN; Groeneveld, AB; Hart, MH; Aarden, LA; Hack, CE. Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation. J Clin Pathol, 2003, 56, 956-959.
160. Eisen, DP; Minchinton, RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis, 2003, 37, 1496-1505.
161. Tsutsumi, A; Takahashi, R; Sumida, T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev, 2005, 4, 364-372.
162. Aittoniemi, J; Baer, M; Soppi, E; Vesikari, T; Miettinen, A. Mannan binding lectin deficiency and concomitant immunodefects. Arch Dis Child, 1998, 78, 245-248.
163. Frakking, FN; Brouwer, N; van Eijkelenburg, NK; Merkus, MP; Kuijpers, TW; Offringa, M; Dolman, KM. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol, 2007, 150, 255-262.
164. de Benedetti, F; Auriti, C; D'Urbano, LE; Ronchetti, MP; Rava, L; Tozzi, A; Ugazio, AG; Orzalesi, MM. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res, 2007, 61, 325-328.
165. Kielgast, S; Thiel, S; Henriksen, TB; Bjerke, T; Olsen, J; Jensenius, JC. Umbilical cord mannan-binding lectin and infections in early childhood. Scand J Immunol, 2003, 57, 167-172.
166. Bodamer, OA; Mitterer, G; Maurer, W; Pollak, A; Mueller, MW; Schmidt, WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet Med, 2006, 8, 518-524.
167. Konishi, M; Nishitani, C; Mitsuzawa, H; Shimizu, T; Sano, H; Harimaya, A; Fujii, N; Himi, T; Kuroki, Y. Alloiococcus otitidis is a ligand for collectins and Toll-like receptor 2, and its phagocytosis is enhanced by collectins. Eur J Immunol, 2006, 36, 1527-1536.
168. Homoe, P; Madsen, HO; Sandvej, K; Koch, A; Garred, P. Lack of association between mannose-binding lectin, acute otitis media and early Epstein-Barr virus infection among children in Greenland. Scand J Infect Dis, 1999, 31, 363-366.
169. Kristensen, IA; Thiel, S; Steffensen, R; Madhi, S; Sorour, G; Olsen, J. Mannan-binding lectin and RSV lower respiratory tract infection leading to hospitalization in children: a case-control study from Soweto, South Africa. Scand J Immunol, 2004, 60, 184-188.
170. Nielsen, HE; Siersma, V; Andersen, S; Gahrn-Hansen, B; Mordhorst, CH; Norgaard-Pedersen, B; Roder, B; Sorensen, TL; Temme, R; Vestergaard, BF. Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study. Acta Paediatr, 2003, 92, 1314-1321.
171. Kase, T; Suzuki, Y; Kawai, T; Sakamoto, T; Ohtani, K; Eda, S; Maeda, A; Okuno, Y; Kurimura, T; Wakamiya, N. Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology, 1999, 97, 385-392.
172. Thielens, NM; Tacnet-Delorme, P; Arlaud, GJ. Interaction of C1q and mannan-binding lectin with viruses. Immunobiology, 2002, 205, 563-574.
173. Kuipers, S; Aerts, PC; Cluysenaer, OJ; Bartelink, AK; Ezekowitz, RA; Bax, WA; Salimans, M; Vandyk, H. A case of familial meningococcal disease due to deficiency in mannose-binding lectin (MBL). Adv Exp Med Biol, 2003, 531, 351-355.
174. Bathum, L; Hansen, H; Teisner, B; Koch, C; Garred, P; Rasmussen, K; Wang, P. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol Immunol, 2006, 43, 473-479.
175. Linton, SM; Morgan, BP. Properdin deficiency and meningococcal disease--identifying those most at risk. Clin Exp Immunol, 1999, 118, 189-191.
176. Truedsson, L; Westberg, J; Fredrikson, GN; Sjoholm, AG; Kuijper, EJ; Fijen, CA; Spath, PJ; Uhlen, M. Human properdin deficiency has a heterogeneous genetic background. Immunopharmacology, 1997, 38, 203-206.
177. Fredrikson, GN; Westberg, J; Kuijper, EJ; Tijssen, CC; Sjoholm, AG; Uhlen, M; Truedsson, L. Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. J Immunol, 1996, 157, 3666-3671.
178. Hibberd, ML; Sumiya, M; Summerfield, JA; Booy, R; Levin, M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet, 1999, 353, 1049-1053.
179. Hamvas, RM; Johnson, M; Vlieger, AM; Ling, C; Sherriff, A; Wade, A; Klein, NJ; Turner, MW; Webster, AD. Role for mannose binding lectin in the prevention of Mycoplasma infection. Infect Immun, 2005, 73, 5238-5240.
180. Marra, MA; Jones, SJ; Astell, CR; Holt, RA; Brooks-Wilson, A; Butterfield, YS; Khattra, J; Asano, JK; Barber, SA; Chan, SY; Cloutier, A; Coughlin, SM; Freeman, D; Girn, N; Griffith, OL; Leach, SR; Mayo, M; McDonald, H; Montgomery, SB; Pandoh, PK; Petrescu, AS; Robertson, AG; Schein, JE; Siddiqui, A; Smailus, DE; Stott, JM; Yang, GS; Plummer, F; Andonov, A; Artsob, H; Bastien, N; Bernard, K; Booth, TF; Bowness, D; Czub, M; Drebot, M; Fernando, L; Flick, R; Garbutt, M; Gray, M; Grolla, A; Jones, S; Feldmann, H; Meyers, A; Kabani, A; Li, Y; Normand, S; Stroher, U; Tipples, GA; Tyler, S; Vogrig, R; Ward, D; Watson, B; Brunham, RC; Krajden, M; Petric, M; Skowronski, DM; Upton, C; Roper, RL. The Genome sequence of the SARS-associated coronavirus. Science, 2003, 300, 1399-1404.
181. Rota, PA; Oberste, MS; Monroe, SS; Nix, WA; Campagnoli, R; Icenogle, JP; Penaranda, S; Bankamp, B; Maher, K; Chen, MH; Tong, S; Tamin, A; Lowe, L; Frace, M; DeRisi, JL; Chen, Q; Wang, D; Erdman, DD; Peret, TC; Burns, C; Ksiazek, TG; Rollin, PE; Sanchez, A; Liffick, S; Holloway, B; Limor, J; McCaustland, K; Olsen-Rasmussen, M; Fouchier, R; Gunther, S; Osterhaus, AD; Drosten, C; Pallansch, MA; Anderson, LJ; Bellini, WJ. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 2003, 300, 1394-1399.
182. Ip, WK; Chan, KH; Law, HK; Tso, GH; Kong, EK; Wong, WH; To, YF; Yung, RW; Chow, EY; Au, KL; Chan, EY; Lim, W; Jensenius, JC; Turner, MW; Peiris, JS; Lau, YL. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis, 2005, 191, 1697-1704.
183. Zhang, H; Zhou, G; Zhi, L; Yang, H; Zhai, Y; Dong, X; Zhang, X; Gao, X; Zhu, Y; He, F. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis, 2005, 192, 1355-1361.
184. Tabona, P; Mellor, A; Summerfield, JA. Mannose binding protein is involved in firstline host defence: evidence from transgenic mice. Immunology, 1995, 85, 153-159.
185. Schelenz, S; Malhotra, R; Sim, RB; Holmskov, U; Bancroft, GJ. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun, 1995, 63, 3360-3366.
186. Marino, MW; Dunn, A; Grail, D; Inglese, M; Noguchi, Y; Richards, E; Jungbluth, A; Wada, H; Moore, M; Williamson, B; Basu, S; Old, LJ. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A, 1997, 94, 8093-8098.
187. Ghezzi, MC; Raponi, G; Angeletti, S; Mancini, C. Serum-mediated enhancement of TNF-alpha release by human monocytes stimulated with the yeast form of Candida albicans. J Infect Dis, 1998, 178, 1743-1749.
188. van Till, JW; Modderman, PW; de Boer, M; Hart, MH; Beld, MG; Boermeester, MA. Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis. Clin Vaccine Immunol, 2008, 15, 65-70.
189. Kaur, S; Gupta, VK; Thiel, S; Sarma, PU; Madan, T. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol, 2007, 148, 382-389.
190. Crosdale, DJ; Poulton, KV; Ollier, WE; Thomson, W; Denning, DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis, 2001, 184, 653-656.
191. Garred, P; Nielsen, MA; Kurtzhals, JA; Malhotra, R; Madsen, HO; Goka, BQ; Akanmori, BD; Sim, RB; Hviid, L. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun, 2003, 71, 5245-5253.
192. Neth, O; Hann, I; Turner, MW; Klein, NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet, 2001, 358, 614-618.
193. Schlapbach, LJ; Aebi, C; Otth, M; Luethy, AR; Leibundgut, K; Hirt, A; Ammann, RA. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer, 2007, 49, 11-16.
194. Peterslund, NA; Koch, C; Jensenius, JC; Thiel, S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet, 2001, 358, 637-638.
195. Siassi, M; Hohenberger, W; Riese, J. Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem Soc Trans, 2003, 31, 774-775.
196. Siassi, M; Riese, J; Steffensen, R; Meisner, M; Thiel, S; Hohenberger, W; Schmidt, J. Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care, 2005, 9, R483-R489.
197. Shi, L; Takahashi, K; Dundee, J; Shahroor-Karni, S; Thiel, S; Jensenius, JC; Gad, F; Hamblin, MR; Sastry, KN; Ezekowitz, RA. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med, 2004, 199, 1379-1390.
198. Thio, CL; Mosbruger, T; Astemborski, J; Greer, S; Kirk, GD; O'Brien, SJ; Thomas, DL. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol, 2005, 79, 9192-9196.
199. Thomas, HC; Foster, GR; Sumiya, M; McIntosh, D; Jack, DL; Turner, MW; Summerfield, JA. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet, 1996, 348, 1417-1419.
200. Yuen, MF; Lau, CS; Lau, YL; Wong, WM; Cheng, CC; Lai, CL. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology, 1999, 29, 1248-1251.
201. Hakozaki, Y; Yoshiba, M; Sekiyama, K; Seike, E; Iwamoto, J; Mitani, K; Mine, M; Morizane, T; Ohtani, K; Suzuki, Y; Wakamiya, N. Mannose-binding lectin and the prognosis of fulminant hepatic failure caused by HBV infection. Liver, 2002, 22, 29-34.
202. Chong, WP; To, YF; Ip, WK; Yuen, MF; Poon, TP; Wong, WH; Lai, CL; Lau, YL. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology, 2005, 42, 1037-1045.
203. Ezekowitz, RA; Kuhlman, M; Groopman, JE; Byrn, RA. A human serum mannosebinding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med, 1989, 169, 185-196.
204. Ying, H; Ji, X; Hart, ML; Gupta, K; Saifuddin, M; Zariffard, MR; Spear, GT. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses, 2004, 20, 327-335.
205. Heggelund, L; Mollnes, TE; Ueland, T; Christophersen, B; Aukrust, P; Froland, SS. Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 2003, 32, 354-361.
206. Maas, J; Roda Husman, AM; Brouwer, M; Krol, A; Coutinho, R; Keet, I; van Leeuwen, R; Schuitemaker, H. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study. AIDS, 1998, 12, 2275-2280.
207. Garred, P; Richter, C; Andersen, AB; Madsen, HO; Mtoni, I; Svejgaard, A; Shao, J. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol, 1997, 46, 204-208.
208. Garred, P; Madsen, HO; Balslev, U; Hofmann, B; Pedersen, C; Gerstoft, J; Svejgaard, A. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet, 1997, 349, 236-240.
209. Nielsen, SL; Andersen, PL; Koch, C; Jensenius, JC; Thiel, S. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol, 1995, 100, 219-222.
210. Prohaszka, Z; Thiel, S; Ujhelyi, E; Szlavik, J; Banhegyi, D; Fust, G. Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease. Immunol Lett, 1997, 58, 171-175.
211. Boniotto, M; Crovella, S; Pirulli, D; Scarlatti, G; Spano, A; Vatta, L; Zezlina, S; Tovo, PA; Palomba, E; Amoroso, A. Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun, 2000, 1, 346-348.
212. Boniotto, M; Braida, L; Pirulli, D; Arraes, L; Amoroso, A; Crovella, S. MBL2 polymorphisms are involved in HIV-1 infection in Brazilian perinatally infected children. AIDS, 2003, 17, 779-780.
213. Heggelund, L; Mollnes, TE; Espevik, T; Muller, F; Kristiansen, KI; Aukrust, P; Froland, SS. Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection. Eur J Clin Invest, 2005, 35, 765-770.
214. Garred, P; Pressler, T; Madsen, HO; Frederiksen, B; Svejgaard, A; Hoiby, N; Schwartz, M; Koch, C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest, 1999, 104, 431-437.
215. Davies, JC; Turner, MW; Klein, N. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J, 2004, 24, 798-804.
216. Eisen, DP; Dean, MM; Thomas, P; Marshall, P; Gerns, N; Heatley, S; Quinn, J; Minchinton, RM; Lipman, J. Low mannose-binding lectin function is associated with sepsis in adult patients. FEMS Immunol Med Microbiol, 2006, 48, 274-282.
217. Fidler, KJ; Wilson, P; Davies, JC; Turner, MW; Peters, MJ; Klein, NJ. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med, 2004, 30, 1438-1445.
218. Garred, P; Strom, J; Quist, L; Taaning, E; Madsen, HO. Association of mannosebinding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis, 2003, 188, 1394-1403.
219. Gordon, AC; Waheed, U; Hansen, TK; Hitman, GA; Garrard, CS; Turner, MW; Klein, NJ; Brett, SJ; Hinds, CJ. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock, 2006, 25, 88-93.
220. Gong, MN; Zhou, W; Williams, PL; Thompson, BT; Pothier, L; Christiani, DC. Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med, 2007, 35, 48-56.
221. Smithson, A; Munoz, A; Suarez, B; Soto, SM; Perello, R; Soriano, A; Martinez, JA; Vila, J; Horcajada, JP; Mensa, J; Lozano, F. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli. Clin Vaccine Immunol, 2007, 14, 256-261.
222. Best, LG; Davidson, M; North, KE; MacCluer, JW; Zhang, Y; Lee, ET; Howard, BV; DeCroo, S; Ferrell, RE. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation, 2004, 109, 471-475.
223. Swanson, AF; Ezekowitz, RA; Lee, A; Kuo, CC. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun, 1998, 66, 1607-1612.
224. Rugonfalvi-Kiss, S; Endresz, V; Madsen, HO; Burian, K; Duba, J; Prohaszka, Z; Karadi, I; Romics, L; Gonczol, E; Fust, G; Garred, P. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation, 2002, 106, 1071-1076.
225. Saevarsdottir, S; Oskarsson, OO; Aspelund, T; Eiriksdottir, G; Vikingsdottir, T; Gudnason, V; Valdimarsson, H. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med, 2005, 201, 117-125.
226. Font, J; Cervera, R; Ramos-Casals, M; Garcia-Carrasco, M; Sents, J; Herrero, C; del Olmo, JA; Darnell, A; Ingelmo, M. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum, 2004, 33, 217-230.
227. Lee, YH; Witte, T; Momot, T; Schmidt, RE; Kaufman, KM; Harley, JB; Sestak, AL. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum, 2005, 52, 3966-3974.
228. Font, J; Ramos-Casals, M; Brito-Zeron, P; Nardi, N; Ibanez, A; Suarez, B; Jimenez, S; Tassies, D; Garcia-Criado, A; Ros, E; Sentis, J; Reverter, JC; Lozano, F. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford), 2007, 46, 76-80.
229. Davies, EJ; Teh, LS; Ordi-Ros, J; Snowden, N; Hillarby, MC; Hajeer, A; Donn, R; Perez-Pemen, P; Vilardell-Tarres, M; Ollier, WE. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J Rheumatol, 1997, 24, 485-488.
230. Saevarsdottir, S; Steinsson, K; Ludviksson, BR; Grondal, G; Valdimarsson, H. Mannan-binding lectin may facilitate the clearance of circulating immune complexes--implications from a study on C2-deficient individuals. Clin Exp Immunol, 2007, 148, 248-253.
231. Ohlenschlaeger, T; Garred, P; Madsen, HO; Jacobsen, S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med, 2004, 351, 260-267.
232. Garred, P; Voss, A; Madsen, HO; Junker, P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun, 2001, 2, 442-450.
233. Takahashi, R; Tsutsumi, A; Ohtani, K; Muraki, Y; Goto, D; Matsumoto, I; Wakamiya, N; Sumida, T. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis, 2005, 64, 311-314.
234. Walport, MJ; Davies, KA; Botto, M. C1q and systemic lupus erythematosus. Immunobiology, 1998, 199, 265-285.
235. Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Muller, S; Kun, JF. Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study. Inflamm Bowel Dis, 2007, 13, 1077-1082.
236. Seibold, F; Konrad, A; Flogerzi, B; Seibold-Schmid, B; Arni, S; Juliger, S; Kun, JF. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. Gastroenterology, 2004, 127, 1076-1084.
237. Joossens, S; Pierik, M; Rector, A; Vermeire, S; Ranst, MV; Rutgeerts, P; Bossuyt, X. Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease. Gut, 2006, 55, 746-
238. Nielsen, RG; Vind, I; Munkholm, P; Jensenius, JC; Thiel, S; Steffensen, R; Husby, S. Genetic polymorphisms of mannan binding lectin (MBL), serum levels of MBL, the MBL associated serine protease and H-ficolin in patients with Crohn's disease. Gut, 2007, 56, 311-312.
239. Boniotto, M; Braida, L; Spano, A; Pirulli, D; Baldas, V; Trevisiol, C; Not, T; Tommasini, A; Amoroso, A; Crovella, S. Variant mannose-binding lectin alleles are associated with celiac disease. Immunogenetics, 2002, 54, 596-598.
240. Boniotto, M; Braida, L; Baldas, V; Not, T; Ventura, A; Vatta, S; Radillo, O; Tedesco, F; Percopo, S; Montico, M; Amoroso, A; Crovella, S. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J Mol Med, 2005, 83, 308-315.
241. de Carvalho, EG; da, RU, Sr.; Silva Kotze, LM; de, MR, I. Serum mannan-binding lectin levels in patients with celiac disease: an analysis of clinical and autoimmune features. Dig Dis Sci, 2007, 52, 2145-2151.
242. Casanova, JL; Abel, L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol, 2002, 20, 581-620.
243. Ridley, DS; Jopling, WH. Classification of leprosy according to immunity. A fivegroup system. Int J Lepr Other Mycobact Dis, 1966, 34, 255-273.
244. Garred, P; Harboe, M; Oettinger, T; Koch, C; Svejgaard, A. Dual role of mannanbinding protein in infections: another case of heterosis? Eur J Immunogenet, 1994, 21, 125-131.
245. Dornelles, LN; Pereira-Ferrari, L; Messias-Reason, I. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms. Clin Exp Immunol, 2006, 145, 463-468.
246. Messias-Reason, IJ; Boldt, AB; Moraes Braga, AC; Rosen Seeling, SE; Dornelles, L; Pereira-Ferrari, L; Kremsner, PG; Kun, JF. The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J Infect Dis, 2007, 196, 1379-1385.
247. Hoal-Van Helden, EG; Epstein, J; Victor, TC; Hon, D; Lewis, LA; Beyers, N; Zurakowski, D; Ezekowitz, AB; Van Helden, PD. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res, 1999, 45, 459-464.
248. Bellamy, R; Ruwende, C; McAdam, KP; Thursz, M; Sumiya, M; Summerfield, J; Gilbert, SC; Corrah, T; Kwiatkowski, D; Whittle, HC; Hill, AV. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM, 1998, 91, 13-18.
249. Soborg, C; Madsen, HO; Andersen, AB; Lillebaek, T; Kok-Jensen, A; Garred, P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis, 2003, 188, 777-782.
250. Reading, PC; Morey, LS; Crouch, EC; Anders, EM. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol, 1997, 71, 8204-8212.
251. Santos, IK; Costa, CH; Krieger, H; Feitosa, MF; Zurakowski, D; Fardin, B; Gomes, RB; Weiner, DL; Harn, DA; Ezekowitz, RA; Epstein, JE. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun, 2001, 69, 5212-5215.
252. Alonso, DP; Ferreira, AF; Ribolla, PE; de, MS, I; do Socorro Pires e Cruz; Aecio, dC; Abatepaulo, AR; Lamounier, CD; Werneck, GL; Farias, TJ; Soares, MJ; Costa, CH. Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications. J Infect Dis, 2007, 195, 1212-1217.
253. Ambrosio, AR; Messias-Reason, IJ. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism. Parasite Immunol, 2005, 27, 333-340.
254. McHutchison, JG. Understanding hepatitis C. Am J Manag Care, 2004, 10, S21-S29.
255. Poupon, R. [Hepatitis C: epidemiology, management and treatment]. Bull Acad Natl Med, 2005, 189, 375-384.
256. Pedroso, MLA; Boldt, AB; Pereira-Ferrari, L; Steffensen, R; Strauss, E; Jensenius, JC; Ioshii, SO; Messias-Reason, I. Mannan-bninding lecting (MBL2) gene polymorphism in chronic hepatitis C: Association with the severity of liver fibrosis and response to interferon therapy. Clin Exp Immunol, 2008, in press-
257. Brown, KS; Keogh, MJ; Tagiuri, N; Grainge, MJ; Presanis, JS; Ryder, SD; Irving, WL; Ball, JK; Sim, RB; Hickling, TP. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBLassociated serine protease 1 (MASP-1) complex. Clin Exp Immunol, 2007, 147, 90-98.
258. Gangadharan, B; Antrobus, R; Dwek, RA; Zitzmann, N. Novel Serum Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients. Clin Chem, 2007
259. Lee, IN; Chen, CH; Sheu, JC; Lee, HS; Huang, GT; Chen, DS; Yu, CY; Wen, CL; Lu, FJ; Chow, LP. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics, 2006, 6, 2865-2873.
260. Matsushita, M; Hijikata, M; Matsushita, M; Ohta, Y; Mishiro, S. Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients. J Hepatol, 1998, 29, 695-700.
261. Homer, C; Shulman, ST. Clinical aspects of acute rheumatic fever. J Rheumatol Suppl, 1991, 29, 2-13.
262. Messias, R, I; Schafranski, MD; Jensenius, JC; Steffensen, R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol, 2006, 67, 991-998.
263. Schafranski, MD; Stier, A; Nisihara, R; Messias-Reason, IJ. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol, 2004, 138, 521-525.
264. Parekh, RB; Dwek, RA; Sutton, BJ; Fernandes, DL; Leung, A; Stanworth, D; Rademacher, TW; Mizuochi, T; Taniguchi, T; Matsuta, K; . Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature, 1985, 316, 452-457.
265. Garred, P; Madsen, HO; Marquart, H; Hansen, TM; Sorensen, SF; Petersen, J; Volck, B; Svejgaard, A; Graudal, NA; Rudd, PM; Dwek, RA; Sim, RB; Andersen, V. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol, 2000, 27, 26-34.
266. Collard, CD; Vakeva, A; Morrissey, MA; Agah, A; Rollins, SA; Reenstra, WR; Buras, JA; Meri, S; Stahl, GL. Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol, 2000, 156, 1549-1556.
267. de Vries, B; Walter, SJ; Peutz-Kootstra, CJ; Wolfs, TG; van Heurn, LW; Buurman, WA. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol, 2004, 165, 1677-1688.
268. Berger, SP; Roos, A; Mallat, MJ; Fujita, T; de Fijter, JW; Daha, MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant, 2005, 5, 1361-1366.
269. Berger, SP; Roos, A; Mallat, MJ; Schaapherder, AF; Doxiadis, II; van Kooten, C; Dekker, FW; Daha, MR; de Fijter, JW. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol, 2007, 18, 2416-2422.
270. Bilgin, YM; Brand, A; Berger, SP; Daha, MR; Roos, A. Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion, 2008
271. Fiane, AE; Videm, V; Lingaas, PS; Heggelund, L; Nielsen, EW; Geiran, OR; Fung, M; Mollnes, TE. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation, 2003, 108, 849-856.
272. Zhang, M; Takahashi, K; Alicot, EM; Vorup-Jensen, T; Kessler, B; Thiel, S; Jensenius, JC; Ezekowitz, RA; Moore, FD; Carroll, MC. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol, 2006, 177, 4727-4734.
273. Collard, CD; Montalto, MC; Reenstra, WR; Buras, JA; Stahl, GL. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol, 2001, 159, 1045-1054.
274. Hisano, S; Matsushita, M; Fujita, T; Endo, Y; Takebayashi, S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis, 2001, 38, 1082-1088.
275. Hisano, S; Matsushita, M; Fujita, T; Iwasaki, H. Activation of the lectin complement pathway in Henoch-Schonlein purpura nephritis. Am J Kidney Dis, 2005, 45, 295-302.
276. Hisano, S; Matsushita, M; Fujita, T; Takeshita, M; Iwasaki, H. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis. Pathol Int, 2007, 57, 351-357.
277. Endo, M; Ohi, H; Ohsawa, I; Fujita, T; Matsushita, M; Fujita, T. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant, 1998, 13, 1984-1990.
278. Endo, M; Ohi, H; Ohsawa, I; Fujita, T; Matsushita, M. Complement activation through the lectin pathway in patients with Henoch-Schonlein purpura nephritis. Am J Kidney Dis, 2000, 35, 401-407.
279. Pirulli, D; Boniotto, M; Vatta, L; Crovella, S; Spano, A; Morgutti, M; Zezlina, S; Bertola, L; Roccatello, D; Scolari, F; Peruzzi, L; Savoldi, S; Amoroso, A. Polymorphisms in the promoter region and at codon 54 of the MBL2 gene are not associated with IgA nephropathy. Nephrol Dial Transplant, 2001, 16, 759-764.
280. Ostergaard, J; Thiel, S; Gadjeva, M; Hansen, TK; Rasch, R; Flyvbjerg, A. Mannosebinding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice. Diabetologia, 2007, 50, 1541-1549.
281. Hansen, TK; Thiel, S; Knudsen, ST; Gravholt, CH; Christiansen, JS; Mogensen, CE; Poulsen, PL. Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab, 2003, 88, 4857-4861.
282. Hansen, TK; Gall, MA; Tarnow, L; Thiel, S; Stehouwer, CD; Schalkwijk, CG; Parving, HH; Flyvbjerg, A. Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med, 2006, 166, 2007-2013.
283. Hovind, P; Hansen, TK; Tarnow, L; Thiel, S; Steffensen, R; Flyvbjerg, A; Parving, HH. Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes, 2005, 54, 1523-1527.
284. Hansen, TK; Tarnow, L; Thiel, S; Steffensen, R; Stehouwer, CD; Schalkwijk, CG; Parving, HH; Flyvbjerg, A. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes, 2004, 53, 1570-1576.
285. Saraheimo, M; Forsblom, C; Hansen, TK; Teppo, AM; Fagerudd, J; Pettersson-Fernholm, K; Thiel, S; Tarnow, L; Ebeling, P; Flyvbjerg, A; Groop, PH. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia, 2005, 48, 198-202.
286. Matsushita, M; Miyakawa, H; Tanaka, A; Hijikata, M; Kikuchi, K; Fujikawa, H; Arai, J; Sainokami, S; Hino, K; Terai, I; Mishiro, S; Gershwin, ME. Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. J Autoimmun, 2001, 17, 251-257.
287. Hellemann, D; Larsson, A; Madsen, HO; Bonde, J; Jarlov, JO; Wiis, J; Faber, T; Wetterslev, J; Garred, P. Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet, 2007, 16, 3071-3080.
288. van de Geijn, FE; Dolhain, RJ; van Rijs, W; Willemsen, SP; Hazes, JM; de Groot, CJ. Mannose-binding lectin genotypes are associated with shorter gestational age An evolutionary advantage of low MBL production genotypes? Mol Immunol, 2008, 45, 1514-1518.
289. Kilpatrick, DC; Starrs, L; Moore, S; Souter, V; Liston, WA. Mannan binding lectin concentration and risk of miscarriage. Hum Reprod, 1999, 14, 2379-2380.
290. Kotze, LM; de Carvalho, EG; Utiyama, SR; Nisihara, RM; Messias-Reason, I. Mannan-binding Lectin Levels Related to Spontaneous Abortion in Brazilian Patients with Celiac Disease. Dig Dis Sci, 2008, accepted for publication-
291. Sziller, I; Babula, O; Hupuczi, P; Nagy, B; Rigo, B; Szabo, G; Papp, Z; Linhares, IM; Witkin, SS. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction. Mol Hum Reprod, 2007, 13, 281-285.
292. Valdimarsson, H. Infusion of plasma-derived mannan-binding lectin (MBL) into MBLdeficient humans. Biochem Soc Trans, 2003, 31, 768-769.
293. Valdimarsson, H; Stefansson, M; Vikingsdottir, T; Arason, GJ; Koch, C; Thiel, S; Jensenius, JC. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol, 1998, 48, 116-123.
294. Salaman, MH. Immunodepression by mammalian viruses and plasmodia. Proc R Soc Med, 1970, 63, 11-15.
295. Summerfield, JA. Clinical potential of mannose-binding lectin-replacement therapy. Biochem Soc Trans, 2003, 31, 770-773.
296. Valdimarsson, H; Vikingsdottir, T; Bang, P; Saevarsdottir, S; Gudjonsson, JE; Oskarsson, O; Christiansen, M; Blou, L; Laursen, I; Koch, C. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol, 2004, 59, 97-102.
297. Mullighan, CG; Heatley, S; Doherty, K; Szabo, F; Grigg, A; Hughes, TP; Schwarer, AP; Szer, J; Tait, BD; Bik, TL; Bardy, PG. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood, 2002, 99, 3524-3529.
298. Kakkanaiah, VN; Shen, GQ; Ojo-Amaize, EA; Peter, JB. Association of low concentrations of serum mannose-binding protein with recurrent infections in adults. Clin Diagn Lab Immunol, 1998, 5, 319-321.
299. Knezevic-Maramica, I; Kruskall, MS. Intravenous immune globulins: an update for clinicians. Transfusion, 2003, 43, 1460-1480.
300. Wallington, T. New uses for IVIgG immunoglobulin therapies. Vox Sang, 2004, 87 Suppl 2, 155-157.
301. Bamshad, M; Wooding, SP. Signatures of natural selection in the human genome. Nat Rev Genet, 2003, 4, 99-111.
302. Mullighan, CG; Marshall, SE; Welsh, KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol, 2000, 51, 111-122.
303. Tin, SK; Lee, LY; Thumboo, J; Koh, DR; Fong, KY. PCR-RFLP genotyping for exon 1 and promoter region mutations of the human mannose binding lectin (MBL-2) gene. J Immunol Methods, 2005, 303, 148-151.
304. Steffensen, R; Hoffmann, K; Varming, K. Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. J Immunol Methods, 2003, 278, 191-199.
305. Van Hoeyveld, E; Houtmeyers, F; Massonet, C; Moens, L; Van Ranst, M; Blanckaert, N; Bossuyt, X. Detection of single nucleotide polymorphisms in the mannose-binding lectin gene using minor groove binder-DNA probes. J Immunol Methods, 2004, 287, 227-230.
306. Roos, A; Dieltjes, P; Vossen, RH; Daha, MR; de Knijff, P. Detection of three single nucleotide polymorphisms in the gene encoding mannose-binding lectin in a single pyrosequencing reaction. J Immunol Methods, 2006, 309, 108-114.
307. Petersen, SV; Thiel, S; Jensen, L; Steffensen, R; Jensenius, JC. An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods, 2001, 257, 107-116.
308. Forster-Waldl, E; Cokoja, L; Forster, O; Maurer, W. Mannose-binding lectin: comparison of two assays for the quantification of MBL in the serum of pediatric patients. J Immunol Methods, 2003, 276, 143-146.
309. Roos, A; Bouwman, LH; Munoz, J; Zuiverloon, T; Faber-Krol, MC; Fallaux-van den Houten FC; Klar-Mohamad, N; Hack, CE; Tilanus, MG; Daha, MR. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol, 2003, 39, 655-668.
310. Seelen, MA; Roos, A; Wieslander, J; Mollnes, TE; Sjoholm, AG; Wurzner, R; Loos, M; Tedesco, F; Sim, RB; Garred, P; Alexopoulos, E; Turner, MW; Daha, MR. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods, 2005, 296, 187-198.
311. Townsend, R; Read, RC; Turner, MW; Klein, NJ; Jack, DL. Differential recognition of obligate anaerobic bacteria by human mannose-binding lectin. Clin Exp Immunol, 2001, 124, 223-228.
312. Davies, J; Neth, O; Alton, E; Klein, N; Turner, M. Differential binding of mannosebinding lectin to respiratory pathogens in cystic fibrosis. Lancet, 2000, 355, 1885-1886.
313. van Emmerik, LC; Kuijper, EJ; Fijen, CA; Dankert, J; Thiel, S. Binding of mannanbinding protein to various bacterial pathogens of meningitis. Clin Exp Immunol, 1994, 97, 411-416.
314. Polotsky, VY; Belisle, JT; Mikusova, K; Ezekowitz, RA; Joiner, KA. Interaction of human mannose-binding protein with Mycobacterium avium. J Infect Dis, 1997, 175, 1159-1168.
315. Laursen, AL; Obel, NS; Holmskov, U; Jensenius, JC; Aliouat, eM; Andersen, PL. Activation of the respiratory burst by Pneumocystis carinii. Efficiency of different antibody isotypes, complement, lung surfactant protein D, and mannan-binding lectin. APMIS, 2003, 111, 405-415.
316. Hartshorn, KL; Sastry, K; White, MR; Anders, EM; Super, M; Ezekowitz, RA; Tauber, AI. Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest, 1993, 91, 1414-1420.
317. Anders, EM; Hartley, CA; Reading, PC; Ezekowitz, RA. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J Gen Virol, 1994, 75 ( Pt 3), 615-622.
318. Hart, ML; Saifuddin, M; Uemura, K; Bremer, EG; Hooker, B; Kawasaki, T; Spear, GT. High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. AIDS Res Hum Retroviruses, 2002, 18, 1311-1317.
319. Ji, X; Gewurz, H; Spear, GT. Mannose binding lectin (MBL) and HIV. Mol Immunol, 2005, 42, 145-152.
320. Saifuddin, M; Hart, ML; Gewurz, H; Zhang, Y; Spear, GT. Interaction of mannosebinding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol, 2000, 81, 949-955.
321. Fischer, PB; Ellermann-Eriksen, S; Thiel, S; Jensenius, JC; Mogensen, SC. Mannanbinding protein and bovine conglutinin mediate enhancement of herpes simplex virus type 2 infection in mice. Scand J Immunol, 1994, 39, 439-445.
322. Gadjeva, M; Paludan, SR; Thiel, S; Slavov, V; Ruseva, M; Eriksson, K; Lowhagen, GB; Shi, L; Takahashi, K; Ezekowitz, A; Jensenius, JC. Mannan-binding lectin modulates the response to HSV-2 infection. Clin Exp Immunol, 2004, 138, 304-311.
323. Kelly, P; Jack, DL; Naeem, A; Mandanda, B; Pollok, RC; Klein, NJ; Turner, MW; Farthing, MJ. Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology, 2000, 119, 1236-1242.
324. Klabunde, J; Uhlemann, AC; Tebo, AE; Kimmel, J; Schwarz, RT; Kremsner, PG; Kun, JF. Recognition of plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system. Parasitol Res, 2002, 88, 113-117.
325. Kahn, SJ; Wleklinski, M; Ezekowitz, RA; Coder, D; Aruffo, A; Farr, A. The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein. Infect Immun, 1996, 64, 2649-2656.
326. den Dunnen, JT; Antonarakis, SE. Nomenclature for the description of human sequence variations. Hum Genet, 2001, 109, 121-124.
327. Colley, KJ; Beranek, MC; Baenziger, JU. Purification and characterization of the corespecific lectin from human serum and liver. Biochem J, 1988, 256, 61-68.